Researchers at the University of Utah are leading clinical trials for a promising new male contraceptive gel, backed by extensive expertise in reproductive health.
Twelve heterosexual couples are enrolled in this rigorous two-year study, part of a nationwide trial funded by the National Institutes of Health (NIH). "In our society, women have long shouldered the primary burden of contraception, bearing the greatest consequences of unintended pregnancy," explains Dr. David Turok, a leading investigator with deep experience in family planning research. "This trial offers men a vital chance to step forward, embracing shared responsibility for contraception and signaling a commitment to a healthier future for couples everywhere."
Hormonal Gel
This innovative gel combines synthetic progesterone Nestorone®, which suppresses natural testosterone production to drastically reduce sperm counts, with supplemental testosterone to preserve libido and essential male functions. Participants apply it daily to their shoulders, allowing for convenient, reliable use.
Beyond efficacy, the study examines how men integrate contraception into their lives, drawing on real-world insights to inform future options.
Testicle Bath
Male contraception is gaining traction. In 2021, designer Rebecca Weiss earned top recognition for COSO, a hormone-free 'testicle bath' device resembling a mini-jacuzzi. It employs warm water and ultrasound to temporarily immobilize sperm, preventing fertilization—all from a quick dip. Effective for up to six months, Weiss is advancing clinical trials toward commercialization.
